Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Exchange Rate Effect (2016 - 2025)

Cytosorbents' Exchange Rate Effect history spans 14 years, with the latest figure at $1.4 million for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $1.4 million for Q4 2025, up 1374.53% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (up 1852.94% YoY), and the annual figure for FY2025 was $1.5 million, up 1852.94%.
  • Exchange Rate Effect for Q4 2025 was $1.4 million at Cytosorbents, up from -$146000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1.4 million in Q4 2025 to a low of -$160491.0 in Q3 2022.
  • The 5-year median for Exchange Rate Effect is $422.0 (2021), against an average of $50876.6.
  • The sharpest move saw Exchange Rate Effect tumbled 3150.12% in 2022, then surged 1374.53% in 2025.
  • Year by year, Exchange Rate Effect stood at $27592.0 in 2021, then skyrocketed by 402.81% to $138734.0 in 2022, then crashed by 171.05% to -$98564.0 in 2023, then dropped by 7.54% to -$106000.0 in 2024, then surged by 1374.53% to $1.4 million in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $1.4 million, -$146000.0, and $259088.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.